Cerebral and tissue oximetry devices market is set to grow at a CAGR of 6.77% from 2022 to 2027, Driven by the growing use of cerebral and tissue oximetry devices in cardiac surgical procedures – Technavio

[ad_2]

NEW YORK, March 3, 2023 /PRNewswire/ — The cerebral and tissue oximetry devices market size is estimated to increase by USD 73.7 million from 2022 to 2027, with a CAGR of 6.77%, according to a recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region.  The growing use of cerebral and tissue oximetry devices in cardiac surgical procedures is notably driving the cerebral and tissue oximetry devices market growth.Patients who undergo cardiac surgery are at risk of adverse perioperative neurological events. The anesthetics used during surgery can lead to anoxia/cerebral hypoxia. Therefore, it is necessary to maintain an adequate supply of oxygen to tissues and organs. These factors are fueling the adoption of advanced blood oxygenation monitoring devices such as cerebral and tissue oximetry devices.For more insights on the historic (2017 to 2021) and forecast market size (2023 to 2027) – Request a sample report

What`s New for 2023?

• Special coverage on the Russia–Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints – Strong/Active/Niche/Trivial
• To procure the data – Buy report!

Vendor Analysis:

The cerebral and tissue oximetry devices market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 vendors listed below –

• Artinis Medical Systems
• Edwards Lifesciences Corp.
• Hamamatsu Photonics KK
• HyperMed Imaging Inc.
• ISS Inc.
• Masimo Corp.
• Medtronic Plc
• Moor Instruments Ltd.
• Nonin Medical Inc.
• Sotera Health Co.
• Spectros Medical Devices Inc.
• Terumo Corp.
• ViOptix Inc.
• To know about the vendor offerings –Download a sample

Chart and data table on 5-year historic (2017-2021) market size, comparative analysis of segments, and Y-O-Y growth of cerebral and tissue oximetry devices market

• The market is segmented by product (modular devices and handheld devices), end-user (hospitals and clinics), and geography (North America, Europe, Asia, and Rest of World (ROW))
• Based on product, the modular devices segment will account for a significant share of the market’s growth during the forecast period.
• Modular cerebral and tissue oximetry devices use a combination of several components, such as monitoring devices, display units, sensor modules, and software packages. These components are integrated and connected to form a modular system.
• The adoption of modular cerebral and tissue oximetry devices has increasing owing to the availability of advanced features and benefits, such as continuous monitoring facilities and the growing adoption of IoT devices in healthcare settings.
• The growing availability of such features is attracting customers, which is driving sales in the modular devices segment.
• These factors will contribute to the growth of the devices market through the modular devices segment during the forecast period.

Chart & data table on historical market size (2017-2021), historic industry size, and analysis of vendors and countries

The market is segmented by region into North America, Europe, Asia, and Rest of World (ROW). An analysis of key leading countries has been included.

• North America is estimated to account for 36% of the growth of the global market during the forecast period. The growth of the regional market is driven by factors such as the rising burden of CVD, the growing number of cardiac surgical procedures, and the increase in US FDA approvals and certifications for cerebral and tissue oximetry devices. The presence of a large number of prominent vendors that offer technologically advanced products is increasing the adoption of the devices in the region.
• The COVID-19 outbreak in North America in 2020 led to the imposition of lockdowns. However, the lifting of lockdown restrictions owing to large-scale vaccination drives led to the resumption of operations in clinics and hospitals. Moreover, the resumption of treatment and surgeries for CVDs, recovery in the regional economy, and the adoption of industry 4.0 in the manufacturing sector will drive the growth of the regional market during the forecast period.

For more insights on the historic (2017 to 2021) and forecast market size (2023 to 2027) – view a PDF sample!

Related Reports:

The breast tissue expander market size is expected to increase by USD 246.39 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 6.55%. This report extensively covers segmentation by product (saline-filled breast tissue expanders and air-filled breast tissue expanders) and geography (North America, Europe, Asia, and Rest of World (ROW)).

The hemostats and tissue sealants market size is expected to increase by USD 2.24 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 9.82%. This report extensively covers market segmentation by product (hemostats, tissue sealants and adhesives, and fibrin sealants) and geography (Europe, APAC, North America, South America, and Middle East and Africa).

Register for a free trial today and gain instant access to 17,000+ market research reports. 

Technavio’s SUBSCRIPTION platform

What are the key data covered in this cerebral and tissue oximetry devices market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the cerebral and tissue oximetry devices market between 2023 and 2027
• Precise estimation of the size of the cerebral and tissue oximetry devices market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the cerebral and tissue oximetry devices market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of cerebral and tissue oximetry devices market vendors

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global cerebral and tissue oximetry devices market 2017 – 2021 
• Exhibit 18: Historic Market Size – Data Table on Global cerebral and tissue oximetry devices market 2017 – 2021 ($ million)

• 4.2 Product Segment Analysis 2017 – 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 – 2021 
• Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 – 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)

• 4.5 Country Segment Analysis 2017 – 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis – Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 30: Chart on Product – Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product – Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Modular devices – Market size and forecast 2022-2027
• Exhibit 34: Chart on Modular devices – Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Modular devices – Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Modular devices – Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Modular devices – Year-over-year growth 2022-2027 (%)

• 6.4 Handheld devices – Market size and forecast 2022-2027
• Exhibit 38: Chart on Handheld devices – Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Handheld devices – Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Handheld devices – Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Handheld devices – Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Product 
• Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 43: Chart on End-user – Market share 2022-2027 (%)
• Exhibit 44: Data Table on End-user – Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 45: Chart on Comparison by End-user
• Exhibit 46: Data Table on Comparison by End-user

• 7.3 Hospitals – Market size and forecast 2022-2027
• Exhibit 47: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)

• 7.4 Clinics – Market size and forecast 2022-2027
• Exhibit 51: Chart on Clinics – Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Clinics – Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Clinics – Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Clinics – Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by End-user 
• Exhibit 55: Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 57: Chart on Market share by geography 2022-2027 (%)
• Exhibit 58: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 59: Chart on Geographic comparison
• Exhibit 60: Data Table on Geographic comparison

• 9.3 North America – Market size and forecast 2022-2027
• Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
• Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
• Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)

• 9.4 Europe – Market size and forecast 2022-2027
• Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)

• 9.5 Asia – Market size and forecast 2022-2027
• Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
• Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)

• 9.7 US – Market size and forecast 2022-2027
• Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)

• 9.8 China – Market size and forecast 2022-2027
• Exhibit 81: Chart on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on China – Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on China – Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on China – Year-over-year growth 2022-2027 (%)

• 9.9 Germany – Market size and forecast 2022-2027
• Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)

• 9.10 France – Market size and forecast 2022-2027
• Exhibit 89: Chart on France – Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on France – Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on France – Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on France – Year-over-year growth 2022-2027 (%)

• 9.11 Japan – Market size and forecast 2022-2027
• Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 97: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 98: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 99: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 100: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 101: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 102: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 103: Matrix on vendor position and classification

• 12.3 Artinis Medical Systems 
• Exhibit 104: Artinis Medical Systems – Overview
• Exhibit 105: Artinis Medical Systems – Product / Service
• Exhibit 106: Artinis Medical Systems – Key offerings

• 12.4 Edwards Lifesciences Corp. 
• Exhibit 107: Edwards Lifesciences Corp. – Overview
• Exhibit 108: Edwards Lifesciences Corp. – Business segments
• Exhibit 109: Edwards Lifesciences Corp. – Key offerings
• Exhibit 110: Edwards Lifesciences Corp. – Segment focus

• 12.5 Hamamatsu Photonics KK 
• Exhibit 111: Hamamatsu Photonics KK – Overview
• Exhibit 112: Hamamatsu Photonics KK – Business segments
• Exhibit 113: Hamamatsu Photonics KK – Key news
• Exhibit 114: Hamamatsu Photonics KK – Key offerings
• Exhibit 115: Hamamatsu Photonics KK – Segment focus

• 12.6 HyperMed Imaging Inc. 
• Exhibit 116: HyperMed Imaging Inc. – Overview
• Exhibit 117: HyperMed Imaging Inc. – Product / Service
• Exhibit 118: HyperMed Imaging Inc. – Key offerings

• 12.7 ISS Inc. 
• Exhibit 119: ISS Inc. – Overview
• Exhibit 120: ISS Inc. – Product / Service
• Exhibit 121: ISS Inc. – Key offerings

• 12.8 Masimo Corp. 
• Exhibit 122: Masimo Corp. – Overview
• Exhibit 123: Masimo Corp. – Product / Service
• Exhibit 124: Masimo Corp. – Key offerings

• 12.9 Medtronic Plc 
• Exhibit 125: Medtronic Plc – Overview
• Exhibit 126: Medtronic Plc – Business segments
• Exhibit 127: Medtronic Plc – Key news
• Exhibit 128: Medtronic Plc – Key offerings
• Exhibit 129: Medtronic Plc – Segment focus

• 12.10 Moor Instruments Ltd. 
• Exhibit 130: Moor Instruments Ltd. – Overview
• Exhibit 131: Moor Instruments Ltd. – Product / Service
• Exhibit 132: Moor Instruments Ltd. – Key offerings

• 12.11 Nonin Medical Inc. 
• Exhibit 133: Nonin Medical Inc. – Overview
• Exhibit 134: Nonin Medical Inc. – Product / Service
• Exhibit 135: Nonin Medical Inc. – Key news
• Exhibit 136: Nonin Medical Inc. – Key offerings

• 12.12 Sotera Health Co. 
• Exhibit 137: Sotera Health Co. – Overview
• Exhibit 138: Sotera Health Co. – Product / Service
• Exhibit 139: Sotera Health Co. – Key offerings

• 12.13 Spectros Medical Devices Inc. 
• Exhibit 140: Spectros Medical Devices Inc. – Overview
• Exhibit 141: Spectros Medical Devices Inc. – Product / Service
• Exhibit 142: Spectros Medical Devices Inc. – Key offerings

• 12.14 Terumo Corp. 
• Exhibit 143: Terumo Corp. – Overview
• Exhibit 144: Terumo Corp. – Business segments
• Exhibit 145: Terumo Corp. – Key news
• Exhibit 146: Terumo Corp. – Key offerings
• Exhibit 147: Terumo Corp. – Segment focus

• 12.15 ViOptix Inc. 
• Exhibit 148: ViOptix Inc. – Overview
• Exhibit 149: ViOptix Inc. – Product / Service
• Exhibit 150: ViOptix Inc. – Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 151: Inclusions checklist
• Exhibit 152: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 153: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 154: Research methodology
• Exhibit 155: Validation techniques employed for market sizing
• Exhibit 156: Information sources

• 13.5 List of abbreviations 
• Exhibit 157: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]

Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/cerebral-and-tissue-oximetry-devices-market-is–set-to-grow-at-a-cagr-of-6-77-from-2022-to-2027–driven-by-the-growing-use-of-cerebral-and-tissue-oximetry-devices-in-cardiac-surgical-procedures—technavio-301759273.html

SOURCE Technavio

Source link
[ad_2]
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

[ad_2]